Literature DB >> 30893091

Meeting the challenges of opioid dependence in China: experience of opioid agonist treatment.

Tianzhen Chen1, Min Zhao1,2.   

Abstract

PURPOSE OF REVIEW: This article reviews the role of methadone maintenance treatment (MMT) clinics in minimizing the harms caused by opioid dependence, as well as China's current challenges in this area. In addition, we aim to discuss the treatment strategies for opioid dependence within the international community in the current global situation of serious abuse of opioids. RECENT
FINDINGS: Like other countries facing the opioid crisis, China is actively working on revising policy, improving the addiction treatment system and promotion of MMT clinics to cope with the risks of opioid abuse. As they provide one of the most effective opioid agonist treatments for opioid dependence, MMT clinics play an extremely important role in this campaign. The MMT programme in China has had a significant beneficial effect on reduction of opioid use and the prevalence rate of HIV/AIDS.
SUMMARY: The efficacy of MMT for patients with opioid dependence in China is confirmed by the present review. However, several important challenges still need to be resolved. China's treatment experience also provides a reference for other countries facing the danger of opioid dependence.

Entities:  

Year:  2019        PMID: 30893091     DOI: 10.1097/YCO.0000000000000509

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  2 in total

1.  Factors Associated with Compliance among Methadone Maintenance Treatment Transfers: Evidence from Audit Records at Clinics in Guangdong, China.

Authors:  Cheng Gong; Xia Zou; Wen Chen; Yin Liu; Qian Lu; Li Ling
Journal:  Int J Environ Res Public Health       Date:  2019-06-06       Impact factor: 3.390

2.  Dose Tapering Strategy for Heroin Abstinence among Methadone Maintenance Treatment Participants: Evidence from A Retrospective Study in Guangdong, China.

Authors:  Qian Lu; Xia Zou; Yin Liu; Cheng Gong; Li Ling
Journal:  Int J Environ Res Public Health       Date:  2019-08-06       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.